Morgan Stanley’s Slimmon warns against buying growth-stock dip

Bad start: Monitors display Dow Jones Industrial Average market data outside the Morgan Stanley headquarters in New York. The Nasdaq Composite Index couldn’t have had a messier kickoff to 2022. — Bloomberg

NEW YORK: Investors should avoid the temptation to buy the dips in expensive high-growth stocks because “once the fever breaks, it lasts a long time,” according to Andrew Slimmon, senior portfolio manager at Morgan Stanley Investment Management.

Slimmon joined the “What Goes Up” podcast to discuss what he’s investing in these days. He also explains how the MSIF United States Core Portfolio fund he co-manages beat the S&P 500 with a 36% gain in 2021. Below are the condensed and lightly edited highlights of the conversation.